Side effect profile of enteric-coated divalproex sodium versus valproic acid [5]

Journal of Clinical Psychiatry

Volumn 61, Issue 9, 2000, Pages 680-681

  Levine, J ^a   Chengappa, K N R ^a   Parepally, H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; THYROXINE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG TOLERABILITY; ENTERIC COATED TABLET; EPILEPSY; GASTROINTESTINAL DISEASE; HUMAN; HYPOTHYROIDISM; LETTER; LEUKOPENIA; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0033803291     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0914h     Document Type: Letter

References (9)

1. Pharmacology, pharmacokinetics, and safety issues of mood-stabilizing agents
2. Valproate-mediated disturbances of hemostasis: Relationship to dose and plasma concentration
3. The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: A pharmacoepidemiology study
4. Blood dyscrasias with carbamazepine and valproate: A pharmacoepidemiological study of 2,228 cases at risk
5. Pharmacokinetics and bioavailability of sodium valproate
6. Twice daily dosing of valproate with divalproex
7. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: A double-blind, concentration-response design clinical trial
8. Thrombocytopenia secondary to high valproate levels in children with epilepsy